Graduate students' views and social influences about oral nicotine pouches
Official title: Health Perceptions and Social Behaviors in Young Adults
Run by Ohio State University Comprehensive Cancer Center · NCT07346092 · Data updated 2026-11-12
We will test whether social-norms and visual risk messages help Ohio State graduate students better understand and share accurate information about the addictive risks of oral nicotine pouches.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Ohio State University Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | March 20, 2025 |
| Main results expected | March 20, 2027 |
| Study ends | March 20, 2027 |
| Registry record updated | March 5, 2026 |
| Trial ID | NCT07346092 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ohio State University graduate students aged 21 or older, with the messaging parts focused on those who are susceptible to, have experimented with, or currently use oral nicotine pouches.
✕Probably not a fit
Individuals under 21, those not affiliated with Ohio State, people not at risk for ONP use, and those already heavily nicotine-dependent are unlikely to receive direct benefit from the messages tested here.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
All participants complete a brief online survey about oral nicotine pouch (ONP) use, perceived norms in their social circles, and interactions with ONP content on social media (Aim 1). Participants identified as susceptible to ONPs, experimental users, or current users (high risk for nicotine dependence) who consent to follow-up are randomized to message-based interventions (Aim 2) or to a comparison of static versus dynamic visual messages (Aim 3). In Aim 2, participants view four randomized messages drawn from a pool of 33 and complete short questionnaires about perceived message effectiveness, knowledge, risk perceptions, and self-efficacy after each message. In Aim 3, participants view either static or dynamic ONP risk messages and report intentions to use and to share ONP-related information.
Why it matters
Potential benefit: If successful, the messaging approach could correct misperceptions about addiction and reduce intentions to use and share information about oral nicotine pouches among young adults.
How similar studies have gone: Prior social-norms and tobacco risk-communication efforts have shown modest success at correcting misperceptions, but targeted evidence for oral nicotine pouches is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * AIM 1: OSU graduate students aged 21 years or older * AIM 2 AND 3: Students identified in Aim 1 as susceptible to ONPs, having experimented with ONPs, or currently using ONPs-those considered at high risk for nicotine dependence-will be invited to participate in Aim 2 or Aim 3 * AIM 3: Participants in Aim 2 will not be invited to participate in Aim 3, as they will have already been exposed to the experimental stimuli
Where it's running
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Megan E Roberts, PhD — Ohio State University Comprehensive Cancer Center
- Study coordinator: The Ohio State University Comprehensive Cancer Center
- Email: OSUCCCClinicaltrials@osumc.edu
- Phone: 1-800-293-5066
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparative evaluation of nicotine analogs for nicotine EC users
This early-stage trial tests whether two nicotine-like compounds (6-MN and nicotinamide) differ from nicotine in how they feel, how much people use them, and how they affect the body in adult e-cigarette users.
-
How nicotine pouches affect users and public health
This study tests different nicotine pouch types and concentrations to see how they feel to users and whether people switch from cigarettes to pouches.
-
Smokefree Family Living to help Chinese American households quit smoking and reduce third‑hand smoke
This trial tests whether a tailored Smokefree Family Living program helps Chinese American smokers and their household members quit smoking and lower third‑hand smoke contamination in their homes.
-
Digital tool to help young adults quit vaping with ACT on Vaping app
A smartphone app using Acceptance and Commitment Therapy is tested to see if it helps 18-30 year-olds quit vaping, compared to a version with enhanced text support.
-
Smoke-free home program for tribal communities
This study tests whether a program that helps tribal communities create smoke-free homes can reduce secondhand smoke exposure and improve health.
-
Manipulating nicotine in e-cigarettes to improve public health
This study tests how different amounts and types of nicotine in e-cigarettes can affect addiction and health risks to help find safer options for smokers and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.